Skip to content

Thrombolytic Therapy In Sub Massive Pulmonary Thromo Emboli

Thrombolytic Therapy Plus Anticoagulant Versus Anticoagulant Alone In Sub Massive Pulmonary Thrombo Embolism: (A Randomized clinical trial )

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014042017343N1
Enrollment
50
Registered
2014-05-18
Start date
2011-04-04
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Thrombo Emboli. Pulmonary embolism with mention of acute cor pulmonale

Interventions

Intervention 1: case group: Enoxaparin 1 milligram per kilogram 2 times a day for 7 days plus thrombolytic( Streptokinase 1500000 unit or Ateplase 100 milligram) in 2 hour. Intervention 2: Control gro
Treatment - Drugs
Control group: only Enoxaparine 1 milligram per killogram 2 times aday for one week
case group: Enoxaparin 1 milligram per kilogram 2 times a day for 7 days plus thrombolytic( Streptokinase 1500000 unit or Ateplase 100 milligram) in 2 hour

Sponsors

cardiovascular research center,Shahid Beheshti University Of Medical Sience
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients between 18 t0 80 years old ;pulmonary thrombo emboli in CT angiography ;right heart involvement in echocardiography;normal bood pressure Exclusion criteria :patients under 18 ;patients under 80 ; normal echocardiography;left heart disease in echocardiography;arterial hypotention

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
In-hospital death. Timepoint: during hospitalization. Method of measurement: observation-.;Clinical deterioration that required an escalation of treatment. Timepoint: during hospitalization. Method of measurement: manometr-blood gas-pulse oximetry.

Secondary

MeasureTime frame
Major Bleeding. Timepoint: During Hospitalization. Method of measurement: Hemoglobin Level.;Right Ventricular Size and Pulmonary Artery Pressure. Timepoint: At The Time Of Discharge. Method of measurement: Echo Cardiology.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Maryam Taherkhani

Shahid Beheshti University Of Medical Sciences

m.taherkhani@sbmu.ac.ir+98 21 5541 9005

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026